These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 16382547)

  • 1. Autoantibodies in prostate cancer.
    Rocco B; Djavan B; de Cobelli O
    N Engl J Med; 2005 Dec; 353(26):2815-7; author reply 2815-7. PubMed ID: 16382547
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoantibodies in prostate cancer.
    Tan EM; Koziol JA
    N Engl J Med; 2005 Dec; 353(26):2815-7; author reply 2815-7. PubMed ID: 16382071
    [No Abstract]   [Full Text] [Related]  

  • 3. Autoantibodies in prostate cancer.
    Kida Y
    N Engl J Med; 2005 Dec; 353(26):2815-7; author reply 2815-7. PubMed ID: 16382546
    [No Abstract]   [Full Text] [Related]  

  • 4. Autoantibodies in prostate cancer.
    Thorat MA; Badwe RA
    N Engl J Med; 2005 Dec; 353(26):2815-7; author reply 2815-7. PubMed ID: 16382548
    [No Abstract]   [Full Text] [Related]  

  • 5. Cancer immunomics: using autoantibody signatures in the early detection of prostate cancer.
    Bradford TJ; Wang X; Chinnaiyan AM
    Urol Oncol; 2006; 24(3):237-42. PubMed ID: 16678056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response as a biomarker for cancer detection and a lot more.
    Finn OJ
    N Engl J Med; 2005 Sep; 353(12):1288-90. PubMed ID: 16177255
    [No Abstract]   [Full Text] [Related]  

  • 7. Autoantibody signatures in prostate cancer.
    Wang X; Yu J; Sreekumar A; Varambally S; Shen R; Giacherio D; Mehra R; Montie JE; Pienta KJ; Sanda MG; Kantoff PW; Rubin MA; Wei JT; Ghosh D; Chinnaiyan AM
    N Engl J Med; 2005 Sep; 353(12):1224-35. PubMed ID: 16177248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PSA doubling time as a predictive factor on repeat biopsy for detection of prostate cancer.
    Shimbo M; Tomioka S; Sasaki M; Shima T; Suzuki N; Murakami S; Nakatsu H; Shimazaki J
    Jpn J Clin Oncol; 2009 Nov; 39(11):727-31. PubMed ID: 19674994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody array profiling reveals serum TSP-1 as a marker to distinguish benign from malignant prostatic disease.
    Shafer MW; Mangold L; Partin AW; Haab BB
    Prostate; 2007 Feb; 67(3):255-67. PubMed ID: 17192876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling tumor-associated autoantibodies for the detection of colon cancer.
    Ran Y; Hu H; Zhou Z; Yu L; Sun L; Pan J; Liu J; Yang Z
    Clin Cancer Res; 2008 May; 14(9):2696-700. PubMed ID: 18451234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a "reverse capture" autoantibody microarray for studies of antigen-autoantibody profiling.
    Qin S; Qiu W; Ehrlich JR; Ferdinand AS; Richie JP; O'leary MP; Lee ML; Liu BC
    Proteomics; 2006 May; 6(10):3199-209. PubMed ID: 16596707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediagnostic C-peptide and risk of prostate cancer.
    Borugian MJ; Spinelli JJ; Sun Z; Kolonel LN; Oakley-Girvan I; Pollak MD; Whittemore AS; Wu AH; Gallagher RP
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2164-5. PubMed ID: 17932367
    [No Abstract]   [Full Text] [Related]  

  • 13. [Detection of prostate cancer: yes or no?].
    Van Cangh PJ
    Bull Mem Acad R Med Belg; 2006; 161(3-4):159-69. PubMed ID: 17172224
    [No Abstract]   [Full Text] [Related]  

  • 14. Is an improved PSA screening test in sight?
    Savage L
    J Natl Cancer Inst; 2007 Oct; 99(20):1503-4. PubMed ID: 17925529
    [No Abstract]   [Full Text] [Related]  

  • 15. Application of prostate-specific antigen in prostate cancer.
    Liang SL
    MLO Med Lab Obs; 2008 Oct; 40(10):54, 56-7. PubMed ID: 18988558
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prostate-specific antigen--the most important cancer marker. Diagnostics and follow up of prostatic cancer have changed].
    Bratt O; Björk T
    Lakartidningen; 2007 Nov 14-20; 104(46):3460-4. PubMed ID: 18072615
    [No Abstract]   [Full Text] [Related]  

  • 17. [Combined assay of serum prostate specific antigen and chromogranin A helps diagnosis of prostate cancer].
    Sun CC; Zheng W; Kong CZ; Wang X; Yang CM
    Zhonghua Nan Ke Xue; 2006 Oct; 12(10):904-5, 909. PubMed ID: 17121020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harnessing immunity for cancer marker discovery.
    Hanash S
    Nat Biotechnol; 2003 Jan; 21(1):37-8. PubMed ID: 12511908
    [No Abstract]   [Full Text] [Related]  

  • 19. [PSA based screening for prostatic cancer].
    Johansen TE
    Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2612-4. PubMed ID: 19023357
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Correction of prostate-specific antigen velocity for variation may improve prediction of cancer following prostate repeat biopsy.
    Singh A
    Can J Urol; 2009 Jun; 16(3):4659. PubMed ID: 19497173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.